DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Celgene (NASDAQ: CELG)



company name or ticker

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Celgene's Plan For Life After Revlimid, With Discussion Of Q1 Earnings

Biotech's Blue Chip Stocks

Traditionally, the consumer goods or technology sector is where you'd find most "blue chip stocks," but over the past decade a number of blue chip stocks have emerged within biotech. Here are the four you should be paying close attention to.

CEO Gives America All A's; the Forbidden Apple: Jim Cramer's Best Blogs

Seeking Alpha's Biotech Weekly: A Gilead Victory, Celladon Crumbles, And More

3 Stocks Reiterated As A Buy: CELG, GM, ORCL

3 Stocks Reiterated As A Buy: CELG, ALXN, GM

Morgan Stanley Looks Over Celgene's Quarter

Analysis of REVLIMID in Patients with Non-Del-5Q MDS Demonstrated Improved Health Related Quality of

Analysis of REVLIMID in Patients with Non-Del-5Q MDS Demonstrated Improved Health Related Quality of Life Measures

Celgene's (CELG) CEO Bob Hugin on Q1 2015 Results - Earnings Call Transcript

See More Articles...